MyoKardia announces proposed public offering of common stock
MyoKardia announced it has commenced a proposed underwritten public offering to sell $200,000,000 in shares of its common stock. MyoKardia expects to grant underwriters a 30-day option to purchase up to $30,000,000 in additional shares of common stock at the public offering price. March 25, 2019